SG11201603360QA - Non-human animals having a humanized b-cell activating factor gene - Google Patents
Non-human animals having a humanized b-cell activating factor geneInfo
- Publication number
- SG11201603360QA SG11201603360QA SG11201603360QA SG11201603360QA SG11201603360QA SG 11201603360Q A SG11201603360Q A SG 11201603360QA SG 11201603360Q A SG11201603360Q A SG 11201603360QA SG 11201603360Q A SG11201603360Q A SG 11201603360QA SG 11201603360Q A SG11201603360Q A SG 11201603360QA
- Authority
- SG
- Singapore
- Prior art keywords
- humanized
- human animals
- activating factor
- cell activating
- factor gene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0325—Animal model for autoimmune diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0381—Animal model for diseases of the hematopoietic system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0387—Animal model for diseases of the immune system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8527—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases
- C12N2015/8536—Animal models for genetic diseases
- C12N2015/8563—Animal models for genetic diseases for autoimmune diseases, e.g. Insulin-dependent diabetes mellitus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361905983P | 2013-11-19 | 2013-11-19 | |
| PCT/US2014/064806 WO2015077071A1 (en) | 2013-11-19 | 2014-11-10 | Non-human animals having a humanized b-cell activating factor gene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201603360QA true SG11201603360QA (en) | 2016-05-30 |
Family
ID=51982794
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201603360QA SG11201603360QA (en) | 2013-11-19 | 2014-11-10 | Non-human animals having a humanized b-cell activating factor gene |
| SG10201900003WA SG10201900003WA (en) | 2013-11-19 | 2014-11-10 | Non-human animals having a humanized b-cell activating factor gene |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201900003WA SG10201900003WA (en) | 2013-11-19 | 2014-11-10 | Non-human animals having a humanized b-cell activating factor gene |
Country Status (16)
| Country | Link |
|---|---|
| US (6) | US20150143558A1 (en) |
| EP (2) | EP3409110A1 (en) |
| JP (1) | JP6505689B2 (en) |
| KR (1) | KR102173260B1 (en) |
| CN (1) | CN105792646B (en) |
| AU (1) | AU2014353346B2 (en) |
| BR (1) | BR112016011003A2 (en) |
| CA (1) | CA2929846C (en) |
| ES (1) | ES2700972T3 (en) |
| HK (1) | HK1258505A1 (en) |
| IL (1) | IL245418B (en) |
| MX (1) | MX356809B (en) |
| MY (1) | MY183188A (en) |
| RU (1) | RU2670016C1 (en) |
| SG (2) | SG11201603360QA (en) |
| WO (1) | WO2015077071A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201603360QA (en) | 2013-11-19 | 2016-05-30 | Regeneron Pharma | Non-human animals having a humanized b-cell activating factor gene |
| HUE051088T2 (en) | 2014-04-08 | 2021-03-01 | Regeneron Pharma | Non-human animals having humanized fc-gamma receptors |
| NO2785538T3 (en) | 2014-05-07 | 2018-08-04 | ||
| SG10201811116UA (en) | 2014-06-19 | 2019-01-30 | Regeneron Pharma | Non-human animals having a humanized programmed cell death 1 gene |
| SI3689140T1 (en) | 2014-11-24 | 2022-10-28 | Regeneron Pharmaceuticals, Inc. | Non-human animals expressing humanized cd3 complex |
| PL3086637T3 (en) | 2014-12-05 | 2019-09-30 | Regeneron Pharmaceuticals, Inc. | NON-HUMAN ANIMALS HAVING A HUMANIZED GEN OF DIFFERENTIAL COMPLEX 47 |
| LT3230320T (en) | 2014-12-09 | 2021-01-11 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized cluster of differentiation 274 gene |
| WO2017087780A1 (en) | 2015-11-20 | 2017-05-26 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized lymphocyte-activation gene 3 |
| CN108779159B (en) | 2016-02-04 | 2022-12-30 | 瑞泽恩制药公司 | Non-human animals with engineered ANGPTL8 genes |
| WO2017151453A1 (en) * | 2016-02-29 | 2017-09-08 | Regeneron Pharmaceuticals, Inc. | Rodents having a humanized tmprss gene |
| SG11202002456WA (en) | 2017-11-30 | 2020-04-29 | Regeneron Pharma | Non-human animals comprising a humanized trkb locus |
| KR20250121150A (en) | 2018-03-26 | 2025-08-11 | 리제너론 파마슈티칼스 인코포레이티드 | Humanized rodents for testing therapeutic agents |
| AU2019308205B2 (en) | 2018-07-16 | 2025-11-06 | Regeneron Pharmaceuticals, Inc. | Non-human animal models of DITRA disease and uses thereof |
| AU2021212668A1 (en) * | 2020-01-28 | 2022-08-18 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized PNPLA3 locus and methods of use |
| IL297315A (en) | 2020-04-21 | 2022-12-01 | Regeneron Pharma | Non-human animals having a humanized cxcl13 gene |
| WO2025212991A1 (en) | 2024-04-05 | 2025-10-09 | Regeneron Pharmaceuticals, Inc. | Rodent models of disease |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1030255A (en) * | 1987-04-14 | 1989-01-11 | 路明尼斯有限公司 | transgenic animals |
| US5175384A (en) * | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5413927A (en) * | 1991-09-03 | 1995-05-09 | North Carolina State University | Feline immunodeficiency virus isolate NCSU1Lb |
| BR0007719A (en) * | 1999-01-25 | 2001-11-13 | Biogen Inc | Baff, related blocking agents and use of the same in stimulating and inhibiting b cells and deimmunoglobulins in immune responses |
| WO2001019842A1 (en) * | 1999-09-17 | 2001-03-22 | Genzyme Transgenics Corporation | Subunit optimized fusion proteins |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| AU2003254001A1 (en) * | 2002-08-14 | 2004-03-03 | Eli Lilly And Company | Novel htnfsf13b protein variants |
| US8853367B1 (en) * | 2004-09-15 | 2014-10-07 | The Uab Research Foundation | Compositions and methods for modulating rank activities |
| DK1802193T3 (en) | 2004-10-19 | 2014-06-10 | Regeneron Pharma | Method of producing a homozygous mouse for genetic modification |
| US7759541B2 (en) * | 2004-12-13 | 2010-07-20 | Iti Life Sciences | Transgenic animals for assessing drug metabolism and toxicity |
| EP1907566A4 (en) * | 2005-05-27 | 2008-12-10 | Memory Pharm Corp | ALZHEIMER TRANSGENIC MOUSE MODEL VECTORS AND USES THEREOF |
| US20070028316A1 (en) * | 2005-06-02 | 2007-02-01 | Xiaoxia Li | Transgenic non-human Act1-deficient mammals and uses thereof |
| US8518392B2 (en) | 2009-08-14 | 2013-08-27 | Regeneron Pharmaceuticals, Inc. | Promoter-regulated differentiation-dependent self-deleting cassette |
| WO2011031835A1 (en) * | 2009-09-09 | 2011-03-17 | The Uab Research Foundation | Chimeric dr5 polypeptides and uses thereof |
| KR102256316B1 (en) * | 2011-02-15 | 2021-05-28 | 리제너론 파마슈티칼스 인코포레이티드 | Humanized m-csf mice |
| RS56656B1 (en) | 2011-10-28 | 2018-03-30 | Regeneron Pharma | Genetically modified major histocompatibility complex mice |
| RU2634417C2 (en) | 2011-10-28 | 2017-10-26 | Регенерон Фармасьютикалс, Инк. | Humanized il-6 and il-6 receptor |
| CA2852962C (en) | 2011-10-28 | 2022-05-03 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules |
| AR090626A1 (en) * | 2012-04-20 | 2014-11-26 | Lilly Co Eli | ANTI-BAFF-ANTI-IL-17 BIESPECIFIC ANTIBODIES |
| EP3939423B1 (en) | 2012-11-05 | 2024-03-06 | Regeneron Pharmaceuticals, Inc. | Genetically modified non-human animals and methods of use thereof |
| PT2958938T (en) | 2013-02-20 | 2019-07-23 | Regeneron Pharma | Mice expressing humanized t-cell co-receptors |
| CN110192541B (en) | 2013-02-22 | 2022-02-18 | 瑞泽恩制药公司 | Mice expressing humanized major histocompatibility complex |
| SMT202300287T1 (en) | 2013-09-23 | 2023-11-13 | Regeneron Pharma | Non-human animals having a humanized signal-regulatory protein gene |
| SG11201603360QA (en) | 2013-11-19 | 2016-05-30 | Regeneron Pharma | Non-human animals having a humanized b-cell activating factor gene |
| CN107529739B (en) * | 2015-04-30 | 2021-01-08 | 株式会社特殊免疫研究所 | Transgenic non-human animals expressing human specific molecules and human Fc gamma receptor family |
-
2014
- 2014-11-10 SG SG11201603360QA patent/SG11201603360QA/en unknown
- 2014-11-10 MX MX2016006511A patent/MX356809B/en active IP Right Grant
- 2014-11-10 ES ES14803022T patent/ES2700972T3/en active Active
- 2014-11-10 AU AU2014353346A patent/AU2014353346B2/en active Active
- 2014-11-10 CN CN201480063161.3A patent/CN105792646B/en active Active
- 2014-11-10 MY MYPI2016000775A patent/MY183188A/en unknown
- 2014-11-10 JP JP2016527255A patent/JP6505689B2/en active Active
- 2014-11-10 KR KR1020167014824A patent/KR102173260B1/en active Active
- 2014-11-10 BR BR112016011003A patent/BR112016011003A2/en not_active Application Discontinuation
- 2014-11-10 SG SG10201900003WA patent/SG10201900003WA/en unknown
- 2014-11-10 CA CA2929846A patent/CA2929846C/en active Active
- 2014-11-10 US US14/537,312 patent/US20150143558A1/en not_active Abandoned
- 2014-11-10 EP EP18185303.7A patent/EP3409110A1/en not_active Withdrawn
- 2014-11-10 EP EP14803022.4A patent/EP3071024B1/en active Active
- 2014-11-10 RU RU2016123708A patent/RU2670016C1/en active
- 2014-11-10 WO PCT/US2014/064806 patent/WO2015077071A1/en not_active Ceased
- 2014-12-05 US US14/561,926 patent/US9629347B2/en active Active
-
2016
- 2016-05-01 IL IL245418A patent/IL245418B/en active IP Right Grant
- 2016-10-12 HK HK19100853.5A patent/HK1258505A1/en unknown
-
2017
- 2017-03-15 US US15/459,453 patent/US10219494B2/en active Active
-
2019
- 2019-01-08 US US16/242,071 patent/US11000020B2/en active Active
-
2021
- 2021-04-09 US US17/226,125 patent/US12058987B2/en active Active
-
2024
- 2024-07-01 US US18/760,465 patent/US12538905B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269907B (en) | Humanized il-15 animals | |
| IL245418A0 (en) | Non-human animals having a humanized b-cell activating factor gene | |
| IL262958A (en) | Non-human animals having a humanized signal-regulatory protein gene | |
| IL245417A0 (en) | Non-human animals having a humanized a proliferation-inducing ligand gene | |
| IL243581A0 (en) | Lincrna-deficient non-human animals | |
| GB2522961B (en) | A terrarium |